Influx Healthtech (NSE:INFLUX) Accounts Payable: ₹191 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:INFLUX Influx Healthtech Ltd NSE:INFLUX
24 GF Score
Price ₹286.35
! 4 Warning Signs
View Full Analysis

What is Influx Healthtech Accounts Payable?

Influx Healthtech NSE:INFLUX -3.13% 24 Accounts Payable is ₹191 Mil as of Mar. 2026. GuruFocus rates NSE:INFLUX with a GF Score™ of 24/100. The stock has 4 warning signs investors should review.

Influx Healthtech's Accounts Payable for the quarter that ended in Mar. 2026 was ₹191 Mil.

Influx Healthtech's quarterly Accounts Payable declined from Mar. 2025 (₹294 Mil) to Sep. 2025 (₹193 Mil) and declined from Sep. 2025 (₹193 Mil) to Mar. 2026 (₹191 Mil).

Influx Healthtech's annual Accounts Payable increased from Mar. 2024 (₹140 Mil) to Mar. 2025 (₹294 Mil) but then declined from Mar. 2025 (₹294 Mil) to Mar. 2026 (₹191 Mil).

Influx Healthtech Accounts Payable Related Terms

Influx Healthtech Accounts Payable Historical Data

* Premium members only.

The historical data trend for Influx Healthtech's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Influx Healthtech Accounts Payable Chart

Influx Healthtech Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Payable
110.35 134.39 139.80 294.20 191.23

Influx Healthtech Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Accounts Payable Get a 7-Day Free Trial 139.80 0.00 294.20 193.02 191.23
NSE:INFLUX
24GF Score
Influx Healthtech Ltd NSE:INFLUX
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Influx Healthtech Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of ₹191 Mil mean?
Influx Healthtech (NSE:INFLUX) has a Accounts Payable of ₹191 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Influx Healthtech and its competitors.
Is Influx Healthtech's Accounts Payable too high?
Influx Healthtech's current Accounts Payable is ₹191 Mil. Overall, Influx Healthtech has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Influx Healthtech's Accounts Payable compare to ZTS?
Influx Healthtech's Accounts Payable of ₹191 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Influx Healthtech and its competitors. Influx Healthtech's current Accounts Payable is ₹191 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Influx Healthtech stock overvalued right now?
Influx Healthtech (NSE:INFLUX) has a current Accounts Payable of ₹191 Mil. The current Accounts Payable is ₹191 Mil. Influx Healthtech's overall GF Score™ is 24/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Influx Healthtech (NSE:INFLUX), the current Accounts Payable is ₹191 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Influx Healthtech Business Description

Address Plot No. 856, 109, Ghanshyam Enclave Premises Co-op Society, Behind Laljipada Police Chowky, Kandivali West, Mumbai, MH, IND, 400067
Influx Healthtech Ltd is a Mumbai-based, healthcare-focused company specialising in contract manufacturing. The company operates manufacturing facilities located in Thane. Its expertise spans the production of Dietary and Nutritional Supplements, Cosmetics, Ayurvedic/Herbal Products, Veterinary Feed Supplements, Homecare Products, Active Pharmaceutical Ingredients (APIs), and finished dosage forms, including tablets, capsules, and injectables. The company generates the majority of its revenue from sale of products.
24GF Score

Get the complete analysis for NSE:INFLUX

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹286.35
Price